OMCL

43.56

0.28% 0.12

Dopo l'orario di chiusura: 43.52 -0.04 -0.09%

Omnicell Inc (OMCL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$43.44

Aprire:

$43.47

Volume 24 ore:

525.99K

Relative Volume:

0.76

Capitalizzazione di mercato:

$1.98B

Reddito:

$1.23B

Utile/perdita netta:

$20.43M

Rapporto P/E:

98.75

EPS:

0.4411

Flusso di cassa netto:

$95.39M

1 W Prestazione:

-4.28%

1M Prestazione:

+27.55%

6M Prestazione:

+21.88%

1 anno Prestazione:

+42.87%

Intervallo 1D:

$42.81

$44.45

Intervallo di 1 settimana:

$41.12

$46.40

Portata 52W:

$22.66

$55.00

Omnicell Inc Stock (OMCL) Company Profile

Nome

Omnicell Inc

Settore

Healthcare (1106)

Industria

Health Information Services (50)

Telefono

(877) 415-9990

Indirizzo

4220 NORTH FREEWAY, FORT WORTH

Dipendente

3,580

Cinguettio

@Omnicell

Prossima data di guadagno

2026-04-28

Ultimi documenti SEC

OMCL's Discussions on Twitter

Compare OMCL vs VEEV, BTSG, TEM, HQY, DOCS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OMCL Omnicell Inc	43.56	1.98B	1.23B	20.43M	95.39M	0.4411
VEEV Veeva Systems Inc	171.19	27.80B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	51.44	10.38B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	54.07	10.01B	1.27B	-245.03M	-245.36M	-1.4071
HQY Healthequity Inc	82.63	6.94B	1.31B	215.20M	408.32M	2.4627
DOCS Doximity Inc	25.77	4.60B	637.78M	239.40M	307.21M	1.1909

Omnicell Inc Stock (OMCL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-04	Aggiornamento	BofA Securities	Neutral → Buy
2026-01-08	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2025-05-14	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-10-31	Downgrade	BofA Securities	Buy → Neutral
2024-08-02	Aggiornamento	Barclays	Underweight → Equal Weight
2024-01-03	Iniziato	Barclays	Underweight
2023-11-03	Downgrade	BTIG Research	Buy → Neutral
2023-11-03	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-11-03	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2023-10-11	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-09-26	Reiterato	Wells Fargo	Underweight
2023-08-02	Downgrade	Piper Sandler	Overweight → Neutral
2023-07-20	Downgrade	Wells Fargo	Overweight → Underweight
2023-02-27	Aggiornamento	The Benchmark Company	Hold → Buy
2022-11-03	Downgrade	The Benchmark Company	Buy → Hold
2022-09-16	Iniziato	KeyBanc Capital Markets	Overweight
2022-09-09	Iniziato	BofA Securities	Buy
2022-07-15	Iniziato	SVB Leerink	Mkt Perform
2021-12-06	Ripresa	Wells Fargo	Overweight
2021-06-09	Iniziato	JP Morgan	Neutral
2021-05-24	Iniziato	BTIG Research	Buy
2021-02-02	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-12-08	Iniziato	Berenberg	Buy
2020-12-03	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-07-07	Iniziato	Stephens	Overweight
2020-02-07	Reiterato	Dougherty & Company	Buy
2019-11-21	Reiterato	Dougherty & Company	Buy
2019-07-26	Aggiornamento	Craig Hallum	Hold → Buy
2019-03-07	Reiterato	Dougherty & Company	Buy
2018-06-29	Ripresa	The Benchmark Company	Buy
2017-09-05	Reiterato	The Benchmark Company	Buy
2017-07-28	Reiterato	Dougherty & Company	Buy
2017-04-21	Downgrade	Piper Jaffray	Overweight → Neutral
2017-01-19	Iniziato	Dougherty & Company	Buy
2016-12-06	Reiterato	The Benchmark Company	Buy
2016-07-07	Reiterato	FBR Capital	Outperform
2016-03-21	Reiterato	Topeka Capital Markets	Buy
2016-01-07	Iniziato	The Benchmark Company	Buy
2015-11-16	Reiterato	Topeka Capital Markets	Buy
2015-10-30	Reiterato	FBR Capital	Outperform
2015-09-28	Aggiornamento	Sidoti	Neutral → Buy
2015-07-31	Reiterato	Topeka Capital Markets	Buy

Mostra tutto

Omnicell Inc Borsa (OMCL) Ultime notizie

May 05, 2026

Omnicell (OMCL) Is Up 13.7% After Earnings Beat, Raised Guidance, And Key Pharmacy HireWhat's Changed - Sahm

May 05, 2026

Omnicell (OMCL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

May 05, 2026

North America Central Fill Pharmacy Automation Market Growth - openPR.com

May 05, 2026

Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell - TradingView

May 05, 2026

Surging earnings estimates signal upside for Omnicell (OMCL) stock - MSN

May 05, 2026

The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call - TradingView

May 05, 2026

Omnicell to Present at the BofA Securities 2026 Healthcare Conference - BioSpace

May 05, 2026

May 04, 2026

Omnicell gets relative strength rating upgrade - MSN

May 04, 2026

Omnicell's May 12 healthcare conference presentation will stream live - Stock Titan

May 04, 2026

Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock - Yahoo Finance

May 04, 2026

Wall Street Analysts See a 41.19% Upside in Omnicell (OMCL): Can the Stock Really Move This High? - Yahoo Finance

May 04, 2026

May 03, 2026

Discipline and Rules-Based Execution in OMCL Response - Stock Traders Daily

May 03, 2026

Assessing Omnicell (OMCL) Valuation After Q1 Earnings Beat And Higher EPS Guidance - Yahoo Finance

May 03, 2026

May 02, 2026

A Look at Omnicell Inc (OMCL) After 3.3% Gain -- GF Value $38.55 vs Price $42.80 - GuruFocus

May 01, 2026

Omnicell (OMCL) Q1 2025 Earnings Transcript - AOL.com

May 01, 2026

Here's why Omnicell (OMCL) is a strong value stock - MSN

May 01, 2026

Omnicell Q1 Earnings & Revenues Top, Stock Up, Gross Margin Rises - Yahoo! Finance Canada

May 01, 2026

Apr 30, 2026

Vanguard holds 2.27M shares in Omnicell (NASDAQ: OMCL) - Stock Titan

Apr 30, 2026

Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Rocket Pharmaceuticals (RCKT) and Cullinan Management (CGEM) - The Globe and Mail

Apr 30, 2026

Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Shattuck Labs (STTK) - The Globe and Mail

Apr 30, 2026

Apr 29, 2026

Omnicell Reports Strong Q1 2026 Earnings, Raises Full-Year GuidanceNews and Statistics - IndexBox

Apr 29, 2026

Omnicell (OMCL) Q1 EPS Recovery Tests Bullish Margin Improvement Narrative - simplywall.st

Apr 29, 2026

Omnicell Earnings Call Shows Profits Surging, Outlook Raised - The Globe and Mail

Apr 29, 2026

Omnicell (NASDAQ:OMCL) Shares Down 7.4%Here's Why - MarketBeat

Apr 29, 2026

Vanguard (NASDAQ: OMCL) owns 3.24M Omnicell shares, 7.13% stake - Stock Titan

Apr 29, 2026

Omnicell appoints Rick Couldry as SVP, chief pharmacy and clinical officer - TipRanks

Apr 29, 2026

Omnicell welcomes hospital pharmacy leader Rick Couldry as senior vice president - marketscreener.com

Apr 29, 2026

Analyst Reiterates Buy on Omnicell, Citing Once-in-a-Decade Product Cycle Momentum and Margin Strength; Price Target Maintained at $70 - TipRanks

Apr 29, 2026

Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer - BioSpace

Apr 29, 2026

Omnicell names Rick Couldry as senior vice president, chief pharmacy and clinical officer - Fort Worth Report

Apr 29, 2026

Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing - The Globe and Mail

Apr 29, 2026

OMCL Maintained by Keybanc -- Price Target Raised to $70 - GuruFocus

Apr 29, 2026

Omnicell Names Rick Couldry Chief Pharmacy and Clinical Officer - Fort Worth Inc.

Apr 29, 2026

KeyBanc raises Omnicell stock price target to $70 on growth outlook By Investing.com - Investing.com South Africa

Apr 29, 2026

KeyBanc raises Omnicell stock price target to $70 on growth outlook - Investing.com Australia

Apr 29, 2026

Omnicell, Inc. (NASDAQ:OMCL) Q1 2026 Earnings Call Transcript - Insider Monkey

Apr 29, 2026

Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry As Senior Vice President - TradingView

Apr 29, 2026

Omnicell Q1 2026 earnings preview - MSN

Apr 29, 2026

TX-OMNICELL-INC. - Black Hills Pioneer

Apr 29, 2026

Omnicell, Inc. Appoints Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer - marketscreener.com

Apr 29, 2026

OMCL Q1 Deep Dive: Platform Expansion and Cost Controls Drive Margin Turnaround - StockStory

Apr 29, 2026